Showing 1,041 - 1,060 results of 174,700 for search '(( 10 ((mean decrease) OR (we decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.67s Refine Results
  1. 1041
  2. 1042
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047

    S3 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
  8. 1048

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
  9. 1049

    S1 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
  10. 1050

    S4 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
  11. 1051

    (A) Decrease in Soret band absorbance; (B) images and the percentages of metmyoglobin (MetMb), deoxymyoglobin (DeoMb) and oxymyoglobin (OxyMb) in native Mb and Mb-GlcN conjugates over glycation period from 0.5 to 12 days. by Yuliya Hrynets (800300)

    Published 2015
    “…<p>(A) Decrease in Soret band absorbance; (B) images and the percentages of metmyoglobin (MetMb), deoxymyoglobin (DeoMb) and oxymyoglobin (OxyMb) in native Mb and Mb-GlcN conjugates over glycation period from 0.5 to 12 days.…”
  12. 1052
  13. 1053
  14. 1054
  15. 1055
  16. 1056
  17. 1057

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…To mitigate the systemic adverse effects of tofacitinib, 5-ASA–PABA–MAC and 5-ASA–PABA–diamine colon-specific delivery systems were constructed, and tofacitinib azo prodrugs <b>9</b> and <b>20a–20g</b> were synthesized accordingly. …”
  18. 1058
  19. 1059
  20. 1060